gastrins and Fatty-Liver

To investigate the effects on non-alcoholic fatty liver disease (NAFLD) in rats of the decoction of Yiqihuoxue formula and the solution prepared with the extracts from the individual herbal medicines of the formula.. The rat models of NAFLD were established with high-fat diet (HFD) for 10 weeks. Thirty-two rats were randomly divided into 4 groups: the control group, the model group, the decoction group and the solution group, 8 for each group. From the 6th week, drinking water, the decoction and the solution were intragastrically administrated accordingly to the rats for 5 weeks. The pathological changes of the liver tissues were observed with Hematoxylin and eosin staining, triglyceride levels in liver tissues measured, serum alanine aminotransferase (ALT) activity measured, and serum gastrin and motilin tested.. Fatty degeneration and vacuole-like changes to various degrees occurred in hepatic cells of the model group. Indicators for fat metabolism, serum ALT activity and hepatic triglyceride level significantly increased, while serum gastrin and motilin levels significantly decreased. Serum ALT activity and the fatty deposition in hepatocytes were significantly reduced. In the meantime, the expressions of gastrin and motilin in the serum rose significantly in the treatment groups.. Both the decoction and the extracts-mixed solution had effect on NAFLD of protecting the liver function and reducing the fatty deposition in liver, which might be achieved by regulating the expression of gastrin and motilin.

Topics: Alanine Transaminase; Animals; Drugs, Chinese Herbal; Fatty Liver; Gastrins; Humans; Liver; Male; Motilin; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Triglycerides

The concentration of gastrin was determined in arterial and venous serum from the head, lung, liver, kidney, and legs in six fasting patients with mild hepatic parenchymatous disease. Extraction of gastrin could not be demonstrated in any of the vascular beds examined. The results indicate that gastrin degradation is not confined to certain specific organs but takes place in many organs or perhaps in the total volume of distribution for gastrin.

Topics: Adult; Biological Transport; Fatty Liver; Femoral Artery; Femoral Vein; Gastrins; Hepatic Veins; Humans; Jugular Veins; Liver; Liver Cirrhosis; Middle Aged; Pulmonary Artery; Renal Veins

Topics: Cholelithiasis; Duodenal Ulcer; Fatty Liver; Gastric Acidity Determination; Gastrins; Gastrointestinal Diseases; Hepatitis; Humans; Lipid Metabolism; Liver Cirrhosis; Liver Diseases; Pancreas; Postgastrectomy Syndromes; Secretin; Sulfobromophthalein

Topics: Amino Acids; Autonomic Nervous System Diseases; Cholecystitis; Duodenal Ulcer; Fatty Liver; Gastric Acidity Determination; Gastrins; Gastritis; Humans; Pancreatitis; Proctitis; Stomach Ulcer